<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script><script>window.ScullyIOAngularDisabled = true;</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">News</a><a routerlink="/glossary" routerlinkactive="active" class="nav-link" href="/glossary">About GARD</a><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">En Espan√µl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 13578 - Myelodysplastic Syndrome With Excess Blasts</h1></div><div><p><b>Other Names: </b>Refractory anemia with excess blasts, RAEB</p><p><b>Categories: </b><!----></p><p><b>This disease is grouped under: </b>Myelodysplastic syndromes</p><p><b>Summary: </b><span><strong>Myelodysplastic syndrome</strong> <strong>with excess blasts</strong> is a rare type of <a href="https://rarediseases.info.nih.gov/diseases/7132/myelodysplastic-syndromes" target="_blank">myelodysplastic syndrome</a> (MDS).[14769] In this type of MDS, the number of very early forms of blood cells (blasts) are increased in the bone marrow and/or blood. There is also a low numbers of at least one type of blood cell. The early forms of cell types in the bone marrow (red blood cells, white blood cells, or platelets) may or may not look abnormal (dysplasia) under the microscope. Signs and symptoms may include a very hard to treat and persistent anemia (refractory anemia),  frequent infections (due to low numbers of neutrophils), easy bruising and bleeding (due to low number or abnormal platelets). MDS with excess blasts<span>&nbsp;</span>is one of the MDS most likely to turn into&nbsp;<a href="https://www.cancer.org/cancer/acute-myeloid-leukemia.html">acute myeloid leukemia (AML)</a>.[14769][14770] It is classified into 2 types, based on how many of the cells in the bone marrow or blood are blasts:[14769][14770][14772]<br>
<ul>
    <li>MDS-EB1<strong>:</strong>&nbsp;blasts make up 5% to 9% of the cells in the bone marrow, or 2% to 4% of the cells in the blood&nbsp;</li>
    <li>MDS-EB2<strong>:</strong>&nbsp;blasts make up 10% to 19% of the cells in the bone marrow, or 5% to 19% of the cells in the blood; this type has a higher risk to become AML. </li>
</ul>
Some cases of MDS are linked to known <a href="https://www.cancer.org/cancer/myelodysplastic-syndrome/causes-risks-prevention/risk-factors.html" target="_blank">risk factors</a> (such as smoking, chemotherapy, having a genetic syndrome that increases the chance of developing MDS and other). These factors lead to changes in the DNA in bone marrow cells may cause MDS to develop, but most often, the cause is unknown.[14771] Treatment may include blood transfusions, supportive care, chemotherapy, radiotherapy and bone marrow transplant.[14770][ 14773][14774]<br></span></p><div><b>Organizations: </b><ul><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=86839" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span>A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Myelodysplastic Syndrome With Excess Blasts. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href="https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries" target="_blank">Learn more about registries</a>.<br>
<br>
Registries for&nbsp;Myelodysplastic Syndrome With Excess Blasts:<br>
<a href="http://pedimds.org/patient/" target="_blank">The Pediatric Myelodysplastic Syndrome (MDS) and Bone Marrow Failure (BMF) Registry</a><br>&nbsp;</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/" target="_blank">NCATS Home</a></div><div class="col"><a href="/sitemap" target="_self">Site Map</a></div><div class="col"><a href="/glossary" target="_self">Browse Glossary A-Z</a></div><div class="col"><a href="/pages/36/privacy-notice" target="_self">Privacy Notice</a></div><div class="col"><a href="/pages/37/disclaimer" target="_self">Disclaimer</a></div><div class="col"><a href="/pages/38/accessibility" target="_self">Accessibility</a></div><div class="col"><a href="/pages/39/foia" target="_self">FOIA </a></div><div class="col"><a href="http://oig.hhs.gov/" target="_blank">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>

<script src="js/custom.js"></script>

</body></html>